209
Views
13
CrossRef citations to date
0
Altmetric
Others

Vitamin D insufficiency and deficiency are associated with a higher level of serum uric acid: A systematic review and meta-analysis

, & ORCID Icon
Pages 385-390 | Received 25 Dec 2018, Accepted 22 Jan 2019, Published online: 04 Mar 2019

References

  • Luk AJ, Simkin PA. Epidemiology of hyperuricemia and gout. Am J Manag Care. 2005;11(15 Suppl.):S435–S42, quiz S65–8.
  • de Oliveira EP, Burini RC. High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr. 2012;4:12.
  • Billiet L, Doaty S, Katz JD, Velasquez MT. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol. 2014;2014:852954.
  • Ganji V, Zhang X, Tangpricha V. Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J Nutr. 2012;142(3):498–507.
  • Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012;33(3):456–92.
  • Pradhan AD, Manson JE. Update on the vitamin D and OmegA-3 trial (VITAL). J Steroid Biochem Mol Biol. 2016;155(Pt B):252–6.
  • J. P. Vitamin D and Longevity (VIDAL) Trial: randomised feasibility study. 11.09.14 (ISRCTN46328341). Available from: http://www.controlled-trials.com/ISRCTN46328341
  • Neale RE, Armstrong BK, Baxter C, Duarte Romero B, Ebeling P, English DR, et al. The D-Health Trial: a randomized trial of vitamin D for prevention of mortality and cancer. Contemp Clin Trials. 2016;48:83–90.
  • T-P. T. Finnish Vitamin D Trial (FIND) 11.09.14 (ClinicalTrials.gov identifier: NCT01463813). Available from: http://www.clinicaltrials.gov/ct2/show/NCT01463813?intr=vitamin+D&outc=cancer&rank=10
  • Chen W, Roncal-Jimenez C, Lanaspa M, Gerard S, Chonchol M, Johnson RJ, et al. Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metab Clin Exp. 2014;63(1):150–60.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.
  • Herzog R, Alvarez-Pasquin MJ, Diaz C, Del Barrio JL, Estrada JM, Gil A. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013;13:154.
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
  • Yilmaz H, Kaya M, Sahin M, Delibasi T. Is vitamin D status a predictor glycaemic regulation and cardiac complication in type 2 diabetes mellitus patients? Diabetes Metab Syndr. 2012;6(1):28–31.
  • Vallianou N, Bountziouka V, Akalestos T, Evangelopoulos A, Vogiatzakis E, Bonou M, et al. Vitamin D status and health correlates among apparently healthy participants in an urban, sunny region. Cent Eur J Public Health. 2012;20(4):262–9.
  • Barker T, Henriksen VT, Rogers VE, Aguirre D, Trawick RH, Lynn Rasmussen G, et al. Vitamin D deficiency associates with γ-tocopherol and quadriceps weakness but not inflammatory cytokines in subjects with knee osteoarthritis. Redox Biol. 2014;2:466–74.
  • Bener A, Al-Hamaq AO, Kurtulus EM, Abdullatef WK, Zirie M. The role of vitamin D, obesity and physical exercise in regulation of glycemia in type 2 diabetes mellitus patients. Diabetes Metab Syndr. 2016;10(4):198–204.
  • Krysiak R, Gilowska M, Okopień B. Different cardiometabolic effects of atorvastatin in men with normal vitamin D status and vitamin D insufficiency. Clin Cardiol. 2016;39(12):715–20.
  • Faridi KF, Lupton JR, Martin SS, Banach M, Quispe R, Kulkarni K, et al. Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk. Arch Med Sci. 2017;13(4):732–7.
  • Chen X, Wu W, Wang L, Shi Y, Shen F, Gu X, et al. Association between 25-hydroxyvitamin D and epicardial adipose tissue in Chinese non-obese patients with type 2 diabetes. Med Sci Monit. 2017;23:4304–11.
  • Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22(4):477–501.
  • Chin K-Y, Ima Nirwana S, Wan Ngah WZ. Significant association between parathyroid hormone and uric acid level in men. Clin Interv Aging. 2015;10:1377–80.
  • Mintz DH, Canary JJ, Carreon G, Kyle LH. Hyperuricemia in hyperparathyroidism. N Engl J Med. 1961;265:112–5.
  • Hui JY, Choi JWJ, Mount DB, Zhu Y, Zhang Y, Choi HK. The independent association between parathyroid hormone levels and hyperuricemia: a national population study. Arthritis Res Ther. 2012;14(2):R56.
  • Hisatome I, Ishimura M, Sasaki N, Yamakawa M, Kosaka H, Tanaka Y, et al. Renal handling of urate in two patients with hyperuricemia and primary hyperparathyroidism. Intern Med. 1992;31(6):807–11.
  • Williams PT. Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr. 2008;87(5):1480–7.
  • Burke BT, Köttgen A, Law A, Windham BG, Segev D, Baer AN, et al. Physical function, hyperuricemia and gout in older adults enrolled in the atherosclerosis risk in communities cohort study. Arthritis Care Res. 2015;67(12):1730–8.
  • Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010;85(8):8–752.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.